KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TherapeuticsMD (TXMD) Other Operating Expenses: 2010-2024

Historic Other Operating Expenses for TherapeuticsMD (TXMD) over the last 15 years, with Dec 2024 value amounting to $1.8 million.

  • TherapeuticsMD's Other Operating Expenses rose 33.33% to $128,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $514,000, marking a year-over-year decrease of 79.37%. This contributed to the annual value of $1.8 million for FY2024, which is 116.18% up from last year.
  • As of FY2024, TherapeuticsMD's Other Operating Expenses stood at $1.8 million, which was up 116.18% from $822,000 recorded in FY2023.
  • TherapeuticsMD's Other Operating Expenses' 5-year high stood at $117.1 million during FY2020, with a 5-year trough of -$7.1 million in FY2021.
  • For the 3-year period, TherapeuticsMD's Other Operating Expenses averaged around $1.1 million, with its median value being $822,000 (2023).
  • Its Other Operating Expenses has fluctuated over the past 5 years, first tumbled by 106.05% in 2021, then soared by 116.18% in 2024.
  • Over the past 5 years, TherapeuticsMD's Other Operating Expenses (Yearly) stood at $117.1 million in 2020, then tumbled by 106.05% to -$7.1 million in 2021, then soared by 108.37% to $593,000 in 2022, then spiked by 38.62% to $822,000 in 2023, then skyrocketed by 116.18% to $1.8 million in 2024.